Ascaphin-8

General Information


DCTPep ID  DCTPep02465

Peptide Name   Ascaphin-8

Sequence  GFKDLLKGAAKALVKTVLF

Sequence Length  19

UniProt ID  P0CJ32 

PubChem CID  16143925 

Origin  Ascaphus truei

Type  Native peptide

Classification

  

ACP Tumor active peptide Membrane lysis



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
HepG2 Hepatoblastoma LC50=20 µM CytoTox 96 non-radiactive cytotoxicity assay  1 h 1

Hemolytic Activity  Human erythrocytes: LC50=55 µM

Normal (non-cancerous) Cytotoxicity  L929 fibroblast-derived cells: LC50=7 µM

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  DCTPep02465

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C97H163N23O23

Absent amino acids  CEHIMNPQRSWY

Theoretical pI  10.00

Acidic residues  1

Basic residues  4

Polar residues  3

Molecular weight (Average)  2019.5

Molecular weight (Monoisotopic)  2018.23

Common amino acids  KL

Net charge  3

Instability index (II)  -13.36

Aliphatic index  128.42

Grand average of hydropathicity (GRAVY)  0.737

Half Life 
  30 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Should not be visible by UV spectrophotometry.

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18554256

Title  Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7

Doi 10.1111/j.1747-0285.2008.00671.x

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_2300

DCTPep is developed by Dr.Zheng's team.